Quallent Pharmaceuticals Health, LLC Recalls

2 recalls found for Quallent Pharmaceuticals Health, LLC. Check if any of your products are affected.

HIGHFDA DRUG

Duloxetine Capsules Recalled Over High N-Nitroso Impurity Risk

Towa Pharmaceuticals recalled 3,397 bottles of Duloxetine Delayed-Release Capsules on November 24, 2025. The recall stems from CGMP deviations resulting in N-nitroso-duloxetine levels exceeding FDA limits. Consumers must stop using the product immediately.

DULOXETINE
CGMP Deviations;
Read more
HIGHFDA DRUG

Duloxetine Capsules Recalled Due to High N-nitroso Impurity

Towa Pharmaceutical Europe recalled 1,856 bottles of Duloxetine delayed-release capsules on July 25, 2025. The recall follows the discovery of N-nitroso-duloxetine impurity exceeding FDA limits. Consumers should stop using the product immediately and seek guidance.

DULOXETINE
CGMP Deviations:
Read more

Brand Statistics

Total Recalls
2
Pages
1

Related Brands

DULOXETINE